🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641
Colorectal Cancer ranks third among the most frequent malignancies represen...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-04
Trial ID
NCT05412706
Treatments Being Tested
The human epidermal growth factor receptor 2 (HER2) regulates cell growth a...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-09-06
Trial ID
NCT03368729
Treatments Being Tested
Randomized phase 3 trial evaluating niraparib plus dostarlimab vs chemother...
Status
Unknown
Location
Azienda Ospedaliera Spedali Civili
Start Date
2020-12-01
Trial ID
NCT04679064
Treatments Being Tested
This is an open-label, multi-center Phase 0 study with an expansion phase t...
Status
Active Not Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2021-10-29
Trial ID
NCT05076513
Treatments Being Tested
Multicentre, 2 arm, open-label UK randomised phase II trial to determine th...
Status
Completed
Location
University Hospital Southampton, Southampton General Hospital
Start Date
2022-07-11
Trial ID
NCT05455424
Treatments Being Tested
This study is designed to evaluate the initial safety and effectiveness of ...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2020-10-19
Trial ID
NCT04288687
Treatments Being Tested
The goal of this Phase 3 clinical trial is to compare the efficacy of nirap...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2024-06-19
Trial ID
NCT06388733
Treatments Being Tested
The purpose of this study is to: a) establish the recommended phase 2 dose ...
Status
Active Not Recruiting
Location
Urological Associates of Southern Arizona, P.C.
Start Date
2018-03-02
Trial ID
NCT03431350
Treatments Being Tested
Carcinosarcomas (CS) (malignant mixed Müllerian tumors) are highly aggressi...
Status
Recruiting
Location
ICO Paul Papin
Start Date
2020-07-15
Trial ID
NCT03651206
Treatments Being Tested